Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice [0.03%]
核微小RNA-204-3p缓解小鼠代谢功能障碍相关性脂肪肝疾病
Zhaowei Zou,Xiu Liu,Jie Yu et al.
Zhaowei Zou et al.
Background & aims: Accumulating evidence has indicated the presence of mature microRNAs (miR) in the nucleus, but their effects on steatohepatitis remain elusive. We have previously demonstrated that the intranuclear miR-...
Systemic metabolic abnormalities: Key drivers of complications and mortality in MASLD [0.03%]
系统性代谢异常：MASLD并发症和死亡率的关键驱动因素
Xiude Fan,Bofei Zhang,Yingzhou Shi et al.
Xiude Fan et al.
HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathway [0.03%]
HIV共感染通过HIF-1α和TGF-β1依赖途径加重HBV诱导的肝纤维化病变
Min Xu,Charlotte Warner,Xiaoqiong Duan et al.
Min Xu et al.
Background & aims: Persons with chronic HBV infection coinfected with HIV experience accelerated progression of liver fibrosis compared to those with HBV monoinfection. We aimed to determine whether HIV and its proteins p...
Familial clustering of MASLD: Rethinking strategies for population screening [0.03%]
MASLD的家庭聚集性：重新考虑人群筛查的策略
Qiaoyue Ge,Zhenmi Liu
Qiaoyue Ge
Treating autoimmune hepatitis - More science, more progress, better therapy [0.03%]
治疗自身免疫性肝炎 – 更多科学，更多进展，更好疗法
Gideon M Hirschfield,Ansgar W Lohse
Gideon M Hirschfield
Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: The answer lies at the interface [0.03%]
自身免疫性肝炎与药物诱导的自身免疫样肝炎的区别：答案在于两者之间的差异
Ahmad Alkashash,Xin Zhang,Raj Vuppalanchi et al.
Ahmad Alkashash et al.
Reply to: "Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea" [0.03%]
《脂肪肝指数的纵向变化与肝细胞癌的风险相关性：韩国全国队列研究》回复
George Cholankeril,Fasiha Kanwal
George Cholankeril
Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice [0.03%]
肝癌管理的治疗方案：临床试验和临床实践中的研究设计
Giuseppe Cabibbo,Ciro Celsa,Lorenza Rimassa et al.
Giuseppe Cabibbo et al.
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide and its prognosis is highly heterogeneous, being related not only to tumour burden but also to the severity of underlying chronic liver disease. Moreover, ...
Reply to: "The impact of infections on the onset of contrast-associated acute kidney injury in patients with cirrhosis" [0.03%]
《感染对肝硬化患者对比剂相关急性肾损伤发病影响的回复》
Daniela Campion,Gian Paolo Caviglia,Carlo Alessandria
Daniela Campion